Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice

International Immunopharmacology

Volumn 13, Issue 1, 2012, Pages 23-27

  Hong, Seong Keun ^a   Kim, Hee Joo ^a   Song, Chang Seon ^a   Choi, In Soo ^a   Lee, Joong Bok ^a   Park, Seung Yong ^a  

^a Konkuk University   (South Korea)

Author keywords

Interleukin 6; Lipopolysaccharide; Nitazoxanide; RAW 264.7 cells; Thioglycollate

Indexed keywords

BETA ACTIN; IMMUNOMODULATING AGENT; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITAZOXANIDE; THIOGLYCOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; IC 50; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR STRUCTURE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIAZOLES; THIOGLYCOLATES; TRANSCRIPTION, GENETIC;

EID: 84859055670     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.03.002     Document Type: Article

References (29)

1. T. Kishimoto Interleukin-6: discovery of a pleiotropic cytokine Arthritis Res Ther 8 Suppl. 2 2006 S2
2. F. Benigni, G. Fantuzzi, S. Sacco, M. Sironi, P. Pozzi, and C.A. Dinarello Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1 Blood 87 1996 1851 1854
3. K. Gijbels, J. Van Damme, P. Proost, W. Put, H. Carton, and A. Billiau Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis Eur J Immunol 20 1990 233 235
4. A.J. Swaak, A. van Rooyen, E. Nieuwenhuis, and L.A. Aarden Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases Scand J Rheumatol 17 1988 469 474
5. P. Vandenabeele, D. Abramowicz, D. Berus, J. Van der Heyden, J. Grooten, and V. Donckier Increased IL-6 production and IL-6-mediated Ig secretion in murine host-vs-graft disease J Immunol 150 1993 4179 4187
6. E. Fattori, C. Della Rocca, P. Costa, M. Giorgio, B. Dente, and L. Pozzi Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice Blood 83 1994 2570 2579
7. T. Putoczki, and M. Ernst More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer J Leukoc Biol 88 2010 1109 1117
8. A.C. White Jr. Nitazoxanide: an important advance in anti-parasitic therapy Am J Trop Med Hyg 68 2003 382 383
9. C.S. McVay, and R.D. Rolfe In vitro and in vivo activities of nitazoxanide against Clostridium difficile Antimicrob Agents Chemother 44 2000 2254 2258
10. F. Megraud, A. Occhialini, and J.F. Rossignol Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole Antimicrob Agents Chemother 42 1998 2836 2840
11. L.V. Ashton, R.L. Callan, S. Rao, and G.A. Landolt In vitro susceptibility of canine influenza A (H3N8) virus to nitazoxanide and tizoxanide Vet Med Int 2010 2010 (article ID 891010)
12. E. Park, W.R. Levis, M.R. Quinn, S.Y. Park, and G.B. Schuller-Levis Regulation of nitric oxide induced by mycobacterial lipoarabinomannan in murine macrophages: effects of interferon-beta and taurine-chloramine Int J Lepr Other Mycobact Dis 68 2000 444 451
13. H. Wan, J.M. Coppens, C.G. van Helden-Meeuwsen, P.J. Leenen, N. van Rooijen, and N.A. Khan Chorionic gonadotropin alleviates thioglycollate-induced peritonitis by affecting macrophage function J Leukoc Biol 86 2009 361 370
14. J.R. Murphy, and J.C. Friedmann Pre-clinical toxicology of nitazoxanide-a new antiparasitic compound J Appl Toxicol 5 1985 49 52
15. F. Fonseca-Salamanca, M.M. Martinez-Grueiro, and A.R. Martinez-Fernandez Nematocidal activity of nitazoxanide in laboratory models Parasitol Res 91 2003 321 324
16. E. van den Enden Pharmacotherapy of helminth infection Expert Opin Pharmacother 10 2009 435 451
17. G. Gargala Drug treatment and novel drug target against Cryptosporidium Parasite 15 2008 275 281
18. D.A. Bobak Use of nitazoxanide for gastrointestinal tract infections: treatment of protozoan parasitic infection and beyond Curr Infect Dis Rep 8 2006 91 95
19. L. Dubreuil, I. Houcke, Y. Mouton, and J.F. Rossignol In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms Antimicrob Agents Chemother 40 1996 2266 2270
20. Y. Guttner, H.M. Windsor, C.H. Viiala, L. Dusci, and B.J. Marshall Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study Antimicrob Agents Chemother 47 2003 3780 3783
21. C. Wenisch, K.F. Linnau, S. Looaresuwan, and H. Rumpold Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria J Infect Dis 179 1999 747 750
22. S. Picot, F. Peyron, A. Donadille, J.P. Vuillez, G. Barbe, and P. Ambroise-Thomas Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism Immunology 80 1993 127 133
23. P.S. Hoffman, G. Sisson, M.A. Croxen, K. Welch, W.D. Harman, and N. Cremades Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni Antimicrob Agents Chemother 51 2007 868 876
24. J. Muller, A. Naguleswaran, N. Muller, and A. Hemphill Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides Exp Parasitol 118 2008 80 88
25. S.T. Qureshi, L. Lariviere, G. Leveque, S. Clermont, K.J. Moore, and P. Gros Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) J Exp Med 189 1999 615 625
26. T. Kawai, and S. Akira Toll-like receptors and their crosstalk with other innate receptors in infection and immunity Immunity 34 2011 637 650
27. E. Andreakos, S.M. Sacre, C. Smith, A. Lundberg, S. Kiriakidis, and T. Stonehouse Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP Blood 103 2004 2229 2237
28. X. Tang, D. Metzger, S. Leeman, and S. Amar LPS-induced TNF-alpha factor (LITAF)-deficient mice express reduced LPS-induced cytokine: evidence for LITAF-dependent LPS signaling pathways Proc Natl Acad Sci U S A 103 2006 13777 13782
29. R.M. Hinson, J.A. Williams, and E. Shacter Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2 Proc Natl Acad Sci U S A 93 1996 4885 4890